IND-enabling studies

MIAMI, September 1, 2026 MIRA Pharmaceuticals, Inc. has reported positive results from completed 7-day dose-range finding toxicology and toxicokinetic...

Guilford, Connecticut, August 20, 2026 Hyperfine announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s...

Wilmington, Massachusetts, August 20, 2026 Charles River Laboratories International and Medigen Vaccine Biologics Corp. (MVC) have entered into a...

AUSTIN, Texas, August 18, 2026 Genprex, Inc. has entered into a development and manufacturing agreement with a leading U.S.-based...

MILWAUKEE, July 21, 2026 Estrigenix Therapeutics announced the first closing of its $2 million Series Seed financing, led by...

DURHAM, N.C., July 9, 2026 Atsena Therapeutics announced the selection of ATSN-401 as its lead clinical candidate for the...

ST. PETERSBURG, Fla., July 1, 2026 ARTAN Bio has announced the successful completion of a $1 million seed financing...

Paris, France, April 7, 2026 Phase 2 Success Across Respiratory Indications In a major advancement for respiratory disease therapeutics,...

KANAGAWA, Japan, Dec. 17, 2025 — PeptiDream Inc. announced promising pre-clinical results for a novel oral dual IL-17A and...